Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
ORPHA:166CategoryAutosomal dominant, Autosomal recessive, X-linked dominant, X-linked recessiveAll ages
Эпидемиология11
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 25 | Europe | Value and class |
| Point prevalence | 1-5 / 10 000 | 15.95 | United Kingdom | Value and class |
| Point prevalence | 6-9 / 10 000 | 61 | Norway | Value and class |
| Point prevalence | 1-5 / 10 000 | 28.2 | Spain | Value and class |
| Point prevalence | 1-5 / 10 000 | 17.5 | Italy | Value and class |
| Point prevalence | 1-5 / 10 000 | 19.55 | Sweden | Value and class |
| Point prevalence | 1-9 / 100 000 | 6.1 | Denmark | Value and class |
| Point prevalence | 1-5 / 10 000 | 12 | Iceland | Value and class |
| Point prevalence | 1-5 / 10 000 | 10.8 | Japan | Value and class |
| Point prevalence | 1-5 / 10 000 | 16 | Cyprus | Value and class |
| Point prevalence | 1-9 / 100 000 | 9.7 | Serbia | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)